Diagnosis: Strongyloides stercoralis disseminated hyperinfection syndrome in an immunocompromised patient on corticosteroids.
5.49-5.89 IV throughout the admission. The patient clinically improved over the next several days, completing 7 sessions of hemodialysis (the final session was day 12 of anthelmintic therapy) and was extubated on hospital day 14. He was transferred out of the intensive care unit on day 17. The abdominal rash resolved by day 14 of treatment (hospital day 24) (Figure 2 ). Continued recovery of kidney function was expected. On hospital day 23, significant increases of white blood cells (WBCs) to 26.4 × 10 3 /µL, absolute eosinophil count to 12.4 × 10 3 /µL, and serum immunoglobulin E (IgE) to 1945 IU/mL were identified, but the patient remained free of clinical symptoms of strongyloidiasis. Immune reconstitution inflammatory syndrome (IRIS) was thought to be the likely cause as the patient's steroids had been weaned considerably since admission. The patient was discharged home on ivermectin and prednisone on hospital day 31.
Strongyloides, a roundworm, exists on all continents except for Antarctica [1] . Two species are known, but S. stercoralis is responsible for most human infections. The parasite is most common in tropical and subtropical areas, particularly Africa, South America, and Southeast Asia. However, infection is also noted in temperate zones, including the southern part of the United States. Mexico encompasses both tropical and temperate zones, and is considered an endemic area [2] . The World Health Organization estimates that 30-100 million people are infected worldwide [3] . Clinical recognition of this parasite is difficult, as patients are often asymptomatic and diagnostic tests including stool examination, serum antigens, and presence of eosinophilia are not adequately sensitive and specific [4, 5] . If not treated, the parasite will persist for the life span of the host due to its autoinfection cycle [3] .
There are 2 cycles in the life of Strongyloides: free-living and parasitic. The free-living cycle occurs strictly in the soil. The parasitic cycle involves invasion of a host following contact with soil or excrement containing Strongyloides filariform larvae. The circulatory system transports cutaneous larvae to the lungs and into the alveoli. The larvae move through the bronchial tree (often via coughing) and into the pharynx. The larvae are then swallowed and travel to the small intestine. After molting, an adult female worm emerges and produces eggs. These eggs then become rhabditiform larvae and either are passed in the stool and enter the free-living cycle or cause autoinfection. In autoinfection, rhabditiform larvae become filariform larvae and enter the mucosa of the intestine or the perianal skin following the same path described above through the lungs or total body dissemination and result in clinical infection [6] .
In hyperinfection, the purpuric lesions on the abdomen and surrounding areas are attributable to migration of larvae through the vessel walls and into the dermis. Minor hemorrhage of the traumatized capillaries results in the petechial appearance [7] . Our patient was hospitalized for 10 days before the lesions appeared. One proposed hypothesis for the unique distribution is that it follows the caput medusae in chronic liver disease [8] . This patient did not have liver disease, but was intubated prior to the appearance of the cutaneous findings. The hypothesis further suggests that because positive pressure ventilation increases portal vein pressure, larvae are freely shunted through the periumbilical portal system to the dermal plexus [8] . Once anthelmintic therapy destroys circulating larvae, capillary trauma ceases and the lesions resolve.
Our patient also developed peritonitis, which is documented in hyperinfection [4, 9] . When larvae migrate across the bowel wall and into the peritoneum, they may carry enteric pathogens, resulting in subsequent infections [9] .
Nephrotic syndrome associated with Strongyloides appears to be uncommon, but was associated with a poor prognosis in a recent case series review [10] . The mechanism is not well defined, but has been proposed to involve immune complex deposition into the renal tissue [11] .
IRIS is described in non-HIV-infected patients who have a dose reduction of corticosteroids [12] . Anthelmintic therapy and significant reduction of corticosteroids in our patient likely contributed to the impressive increases in WBCs, eosinophils, and IgE levels. However, the serologic markers of worsened parasitic infection were not clinically correlated.
This case demonstrates the need for Strongyloides screening in at-risk populations prior to initiation of immunosuppressive therapy. The Centers for Disease Control and Prevention recommends that prescribers should consider screening patients prior to/during immunosuppressant therapy or in patients with known HTLV-1 infection, hematologic malignancy, organ transplant, eosinophilia, or a history of travel to an endemic area [5] .
